NPI: 1174597033 · INGLEWOOD, CA 90301 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/15/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/15/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| DVA RENAL HEALTHCARE INC | SELLS | AZ | $7.17M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 8,140 | $1.99M |
| 2019 | 7,881 | $962K |
| 2020 | 9,977 | $1.40M |
| 2021 | 14,647 | $1.22M |
| 2022 | 8,775 | $1.25M |
| 2023 | 9,338 | $1.47M |
| 2024 | 9,528 | $1.16M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 36,304 | 4,103 | $7.01M |
| 0821 | 2,287 | 636 | $2.20M | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 8,933 | 1,326 | $137K |
| J1756 | Injection, iron sucrose, 1 mg | 5,017 | 1,836 | $39K |
| J1270 | Injection, doxercalciferol, 1 mcg | 4,860 | 902 | $39K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 982 | 575 | $16K |
| 83970 | 960 | 933 | $5K | |
| 0250 | 2,758 | 178 | $5K | |
| A4657 | Syringe, with or without needle, each | 2,574 | 1,381 | $4K |
| 90674 | 84 | 84 | $2K | |
| 82728 | 337 | 320 | $1K | |
| 83550 | 309 | 295 | $706.14 | |
| 83540 | 337 | 322 | $526.75 | |
| 82108 | 59 | 59 | $428.84 | |
| 85048 | 1,025 | 963 | $322.47 | |
| 85041 | 1,009 | 951 | $322.12 | |
| 0302 | 230 | 122 | $171.41 | |
| 90662 | 43 | 43 | $73.55 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 49 | 31 | $12.93 |
| G0008 | Administration of influenza virus vaccine | 25 | 25 | $2.66 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 91 | 84 | $0.00 |
| 82746 | 13 | 13 | $0.00 |